leisure time -WSS

leisure time

author：explore 2025-10-01 11:35:03 - browse：36153

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Dana Farber says 6 studies to be retracted and 31 corrected

entertainment

WSS

An outdated Medicare rule harms dementia patients with anxiety

High breast density mammograms need follow

CMS got Medicare Advantage quality rating wrong, judge rules

Eli Lilly’s Zepbound improved liver scarring in mid

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

To bolster infectious disease surveillance, genomics powerhouses team up

knowledge

leisure time

Wikipedia

In Memoriam: Notable people who died in 2023

FDA endorses new sterilization method for medical devices

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Immunocompromised patients offer clues on chronic Covid

Supreme Court strikes down use of affirmative action

Stopping antidepressants leads to symptoms for 1 in 6 patients

Medical records are filled with copy

There's an unseen cost to disruptive road

Wikipedia

Medicare bonuses could stop drug shortages under Senate plan

How CO2 helps viruses stay alive longer in the air

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Elevance PBM president out as customers face prescription chaos

The inclusion problem at the heart of rehabilitation research

entertainment

focus

hotspot

hotspot